GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Selvita SA (FRA:787) » Definitions » Other Income (Expense)

Selvita (FRA:787) Other Income (Expense) : €13.84 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Selvita Other Income (Expense)?

Selvita's other income expense for the Selvita's pretax income for the three months ended in Sep. 2024 was €-0.02 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2024 was €13.84 Mil.


Selvita Other Income (Expense) Historical Data

The historical data trend for Selvita's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Selvita Other Income (Expense) Chart

Selvita Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only - -0.02 -0.27 - 14.33

Selvita Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 14.23 -0.17 -0.20 -0.02

Selvita Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €13.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Selvita  (FRA:787) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Selvita Business Description

Traded in Other Exchanges
Address
Bobrzynskiego 14, Park Life Science, Krakow, POL, 30-348
Selvita SA is a Poland based parent company of Selvita Group is one of the largest preclinical contract research organizations in Europe. It also develops bioinformatics solutions supporting innovative projects at preclinical stages. It also provides services provided to external contractors are in the field of chemistry, analytics, regulatory, biochemistry and cell biology and also the integrated research and development projects.

Selvita Headlines

No Headlines